17,052
edits
Changes
Jump to navigation
Jump to search
Add population section.
* Nairobi, Kenya
Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a {{PhD}} in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, [[HIV]]/[[AIDS]], health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for [[HIV]] prevention in Kisumu Kenya, study of wound healing following medical circumcision of [[HIV]]+ve and [[HIV]]-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of [[Prepex|PrePex]] for [[circumcision ]] in Kenya and active AE surveillance for ShangRing circumcision.
He currently serves as technical lead for [[CDC]]/[[PEPFAR]] supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of [[VMMC]] implementation. As long serving member of Kenya’s national [[VMMC]] TWG he has a rich experience in development of standard operating procedures and guidelines for [[VMMC]] service delivery in Kenya and other African countries.<ref>{{REFdocument
Odoyo-June is currently employed by the United States Centers for Disease Control and Prevention to actively promote non-therapeutic male circumcision in Africa. PubMed reveals that he is a named author of twenty-one papers, all of which promote non-therapeutic male circumcision in some way. [[Robert C. Bailey]] is a co-author of thirteen of the articles. It would be hard to conceive of a person more biased in favor of non-theapeutic male circumcision.
==Population-based studies==
September 2021 saw the publication of two huge population studies on the relationship of [[circumcision]] and HIV infection:
# Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, [[Canada]] (569,950 males), of whom 203,588 (35.7%) were [[circumcised]] between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.<ref name="mayan2021">{{REFjournal
|last=Mayan
|first=Madhur
|init=M
|author-link=
|last2=Hamilton
|first2=Robert J.
|init2=RJ
|author2-link=
|last3=Juurlink
|first3=David N.
|init3=DN
|author3-link=
|last4=Austin
|first4=Peter C.
|init4=PC
|author4-link=
|last5=Jarvi
|first5=Keith A.
|init5=KA
|author5-link=
|etal=no
|title=Circumcision and Risk of HIV Among Males From Ontario, Canada
|journal=J Urol
|date=2021-09-23
|url=https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002234
|quote=We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
|pubmedID=34551593
|DOI=10.1097/JU.0000000000002234
|accessdate=2021-10-02
}}</ref>
# [[Morten Frisch]] & Jacob Simonsen (2021) carried out a large scale empirical population study in [[Denmark]] of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that [[circumcised]] men have a higher rate of STI and HIV infection overall than [[intact]] men.<ref name="frisch2021">{{FrischM SimonsenJ 2021}}</ref>
No association between lack of circumcision and risk of HIV infection was found by either study.
{{SEEALSO}}